1. Could you please tell me how many patients your Trust has treated in the past 6 months (for any disease) with the following:
a. Ruxolitinib – any strength
b. Ruxolitinib 5mg tablets or Ruxolitinib 10mg tablets
2. In case you are able to link Ruxolitinib usage to disease, could you also provide the number of patients treated in the last 6 months for myelofibrosis ONLY with
a. Ruxolitinib – any strength
b. Ruxolitinib 5mg tablets or Ruxolitinib 10mg tablets
